Moleculin Biotech, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Moleculin Biotech, Inc. (MBRX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$4.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-11
- Moleculin Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$4.00K, a 113.33% decline year-over-year.
- Moleculin Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $0.00.
- Moleculin Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$11.31K.
- Moleculin Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$109.79K.
- Moleculin Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$121.11K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 2 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 5 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$4.00K 10-Q · filed 2017-08-11 | -$15.31K derived: sum of 3 quarters · filed 2017-08-11 | -$125.11K derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | -$11.31K derived: sum of 2 quarters · filed 2017-05-12 | -$121.11K derived: sum of 3 quarters · filed 2017-05-12 | -$91.11K derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2016-12-31 | -$11.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03 | -$121.11K derived: sum of 2 quarters · filed 2017-04-03 | -$91.11K derived: sum of 3 quarters · filed 2017-08-11 | -$121.11K 10-K · filed 2017-04-03 | |||
| 2016-09-30 | -$109.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-21 | -$79.79K derived: sum of 2 quarters · filed 2017-08-11 | -$109.79K 10-Q · filed 2016-11-21 | ||||
| 2016-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $362.00 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | -$30.00K 10-Q · filed 2017-05-12 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2017-04-03 | ||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |